Literature DB >> 10675353

Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

J Wijnholds1, E C deLange, G L Scheffer, D J van den Berg, C A Mol, M van der Valk, A H Schinkel, R J Scheper, D D Breimer, P Borst.   

Abstract

Multidrug resistance protein 1 (MRP1) is a transporter protein that helps to protect normal cells and tumor cells against the influx of certain xenobiotics. We previously showed that Mrp1 protects against cytotoxic drugs at the testis-blood barrier, the oral epithelium, and the kidney urinary collecting duct tubules. Here, we generated Mrp1/Mdr1a/Mdr1b triple-knockout (TKO) mice, and used them together with Mdr1a/Mdr1b double-knockout (DKO) mice to study the contribution of Mrp1 to the tissue distribution and pharmacokinetics of etoposide. We observed increased toxicity in the TKO mice, which accumulated etoposide in brown adipose tissue, colon, salivary gland, heart, and the female urogenital system. Immunohistochemical staining revealed the presence of Mrp1 in the oviduct, uterus, salivary gland, and choroid plexus (CP) epithelium. To explore the transport function of Mrp1 in the CP epithelium, we used TKO and DKO mice cannulated for cerebrospinal fluid (CSF). We show here that the lack of Mrp1 protein causes etoposide levels to increase about 10-fold in the CSF after intravenous administration of the drug. Our results indicate that Mrp1 helps to limit tissue distribution of certain drugs and contributes to the blood-CSF drug-permeability barrier.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675353      PMCID: PMC377447          DOI: 10.1172/JCI8267

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Micronutrient homeostasis in mammalian brain and cerebrospinal fluid.

Authors:  R Spector
Journal:  J Neurochem       Date:  1989-12       Impact factor: 5.372

2.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Authors:  C Cordon-Cardo; J P O'Brien; D Casals; L Rittman-Grauer; J L Biedler; M R Melamed; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  The mammalian choroid plexus.

Authors:  R Spector; C E Johanson
Journal:  Sci Am       Date:  1989-11       Impact factor: 2.142

4.  Leukotriene C4 transport and metabolism in the central nervous system.

Authors:  R Spector; E J Goetzl
Journal:  J Neurochem       Date:  1986-04       Impact factor: 5.372

5.  The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicyclic acid and iodide.

Authors:  R Spector; A V Lorenzo
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

6.  Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein.

Authors:  J Nishino; H Suzuki; D Sugiyama; T Kitazawa; K Ito; M Hanano; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

7.  Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney.

Authors:  K C Peng; F Cluzeaud; M Bens; J P Duong Van Huyen; M A Wioland; R Lacave; A Vandewalle
Journal:  J Histochem Cytochem       Date:  1999-06       Impact factor: 2.479

Review 8.  Toxicity of non-steroidal anti-inflammatory drugs in the large bowel.

Authors:  J L Faucheron
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-04       Impact factor: 2.566

9.  Transport of prostaglandins and other eicosanoids by the choroid plexus: its characterization and physiological significance.

Authors:  F E DiBenedetto; L Z Bito
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

10.  Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.

Authors:  T Nohjoh; H Suzuki; Y Sawada; Y Sugiyama; T Iga; M Hanano
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

View more
  73 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Bilirubin, a curse and a boon.

Authors:  J D Ostrow; C Tiribelli
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

4.  Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells.

Authors:  Aniko Somogyvari-Vigh; Abba J Kastin; Jie Liao; James E Zadina; Weihong Pan
Journal:  Exp Brain Res       Date:  2004-05       Impact factor: 1.972

Review 5.  The controversial role of ABC transporters in clinical oncology.

Authors:  Akina Tamaki; Caterina Ierano; Gergely Szakacs; Robert W Robey; Susan E Bates
Journal:  Essays Biochem       Date:  2011-09-07       Impact factor: 8.000

Review 6.  ABC transporters: unvalidated therapeutic targets in cancer and the CNS.

Authors:  Robert W Robey; Paul R Massey; Laleh Amiri-Kordestani; Susan E Bates
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

7.  Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

Authors:  Susanne May; Scott Letendre; Richard Haubrich; J Allen McCutchan; Robert Heaton; Edmund Capparelli; Ronald Ellis
Journal:  J Neuroimmune Pharmacol       Date:  2007-01-10       Impact factor: 4.147

Review 8.  Pharmacogenetics of membrane transporters: an update on current approaches.

Authors:  Tristan M Sissung; Caitlin E Baum; C Tyler Kirkland; Rui Gao; Erin R Gardner; William D Figg
Journal:  Mol Biotechnol       Date:  2010-02       Impact factor: 2.695

9.  Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Authors:  Robert L Myette; Gwenaëlle Conseil; Sean P Ebert; Bryan Wetzel; Michael R Detty; Susan P C Cole
Journal:  Drug Metab Dispos       Date:  2013-03-25       Impact factor: 3.922

10.  The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin.

Authors:  Igino Rigato; Lorella Pascolo; Cristina Fernetti; J Donald Ostrow; Claudio Tiribelli
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.